儿科医疗集团
MD
27.38
-0.38
-1.37%
儿科医疗集团
US · MD
#2735 按市值排名
上市于 1970
27.38
-0.38
-1.37%
实时 - 追踪5344个代码 - 心跳于439秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量减少了2家。
- 机构持股总比例下降了0.2个百分点。
机构持股
- 机构持股比例
- 106.75% -0.23pp
- 机构数量
- 359 -2
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund93.44%
Hedge Fund6.24%
Public Company3.07%
Government Pension Fund2.56%
Individual/Insider1.63%
Private Company0.61%
Family Office/Trust0.34%
Bank/Investment Bank0.24%
Insurance Company0.11%
主要股东 截至 2026-06-30
BlackRock
17.29% · 13.71M 股
Vanguard Portfolio Management, LLC
7.55% · 5.99M 股
Dimensional Fund Advisors
5.32% · 4.22M 股
Vanguard Capital Management, LLC
5.24% · 4.15M 股
State Street Global Advisors
4.45% · 3.53M 股
Victory Capital Management Inc.
4.31% · 3.42M 股
Wasatch Advisors LP
3.15% · 2.50M 股
Geode Capital Management, LLC
2.81% · 2.23M 股
American Century Investment Management
2.76% · 2.19M 股
Fuller & Thaler Asset Management, Inc.
2.17% · 1.72M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 30次买入 · 20次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Mark Ordan | Chair | 0.52% |
| Mary Ann Moore | General Counsel | 0.24% |
| D. Neeb | Executive VP and Chief Investment & Strategy Officer | 0.17% |
| Kasandra Rossi | Senior Vice President of Financial Reporting & Assistant Treasurer | 0.13% |
| Guy Sansone | Lead Independent Director | 0.11% |
| Thomas McEachin | Independent Director | 0.09% |
| John Starcher | Independent Director | 0.09% |
| Michael Rucker | Independent Director | 0.08% |
| Laura McDuffie | -- | 0.04% |
| Sylvia Young | Independent Director | 0.04% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-09 | Laura McDuffie | -- | Sale to Issuer | -6,000 | $26.82 |
| 2026-08-13 | Sylvia Young | Independent Director | Sale to Issuer | -18,500 | $26.62 |
| 2026-08-11 | Guy Sansone | Lead Independent Director | Other Acquisition | +472 | $26.50 |
| 2026-08-11 | Thomas McEachin | Independent Director | Other Acquisition | +472 | $26.50 |
| 2026-08-11 | Sylvia Young | Independent Director | Other Acquisition | +472 | $26.50 |
| 2026-08-11 | John Starcher | Independent Director | Other Acquisition | +472 | $26.50 |
| 2026-08-11 | Shirley Weis | Independent Director | Other Acquisition | +472 | $26.50 |
| 2026-08-11 | Kurt Newman | Independent Director | Other Acquisition | +472 | $26.50 |
| 2026-08-11 | Laura McDuffie | -- | Other Acquisition | +472 | $26.50 |
| 2026-08-11 | Michael Rucker | Independent Director | Other Acquisition | +472 | $26.50 |
| 2026-06-21 | David Haddock | -- | Other Acquisition | +20,036 | -- |
| 2026-06-21 | David Haddock | -- | Other Derivative Acquisition | +51,000 | -- |
| 2026-06-08 | Mary Ann Moore | General Counsel | Other Acquisition | +18,407 | -- |
| 2026-06-08 | Mary Ann Moore | General Counsel | Other Disposition | -18,407 | -- |
| 2026-06-01 | Mark Ordan | Chair | Sale to Issuer | -116,293 | $21.54 |
| 2026-06-01 | Mark Ordan | Chair | Other Acquisition | +224,372 | -- |
| 2026-05-31 | D. Neeb | Executive VP and Chief Investment & Strategy Officer | Sale to Issuer | -8,003 | $21.54 |
| 2026-05-31 | D. Neeb | Executive VP and Chief Investment & Strategy Officer | Other Acquisition | +63,888 | -- |
| 2026-05-31 | Mary Ann Moore | General Counsel | Sale to Issuer | -11,944 | $21.54 |
| 2026-05-31 | Kasandra Rossi | Senior Vice President of Financial Reporting & Assistant Treasurer | Sale to Issuer | -3,701 | $21.54 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
儿科医疗集团 讨论区 0 条评论